EUVIMEDEUVIMED entdecken
Crossref

HERC5/ISG15 Enhances Glioblastoma Stemness and Tumor Progression by mediating SERBP1protein stability

Zhixiao Li, Rongjun Qian, Mengda Li, Juntao Li, Yongji Guo, Yuanhang Zhou, Chunxiao Ma

NeuroMolecular Medicine · 07.01.2025 · 27 (1)

DOI: 10.1007/s12017-024-08826-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroMolecular Medicine, online erschienen am 07.01.2025. Verfasst von Zhixiao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, Henan Province, China. Hauptthemen laut MEDLINE: Glioblastoma, Ubiquitins, Neoplastic Stem Cells, Brain Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common malignant brain tumor, and has a low survival rate and a poor prognosis. Intensive studies of pathogenic mechanisms are essential for exploring therapeutic targets for GBM. In this study, the roles played by interferon-stimulated gene 15 (ISG15), HECT, RCC1-containing protein 5 (HERC5), and SERPINE1 mRNA binding protein 1 (SERBP1) in regulating GBM cell stemness were investigated. The real-time quantitative polymerase chain reaction (qPCR), western blotting (WB), and immunohistochemistry (IHC) were used to determine the expression levels of HERC5, ISG15, and SERBP1. Cell stemness was analyzed using a cell sphere formation assay. Colony formation and cell counting kit-8 (CCK-8) assays were performed to assess cell proliferation, Transwell assays used to evaluate cell migration and invasion, and flow cytometry was used to assess cell apoptosis after treatment with temozolomide. SERBP1 stability was assessed by a CHX chase assay. A co-immunoprecipitation (Co-IP) assay verified the binding of ISG15 and HERC5 onto SERBP1. Our results showed that HERC5 and ISG15 were highly expressed in GBM. HERC5 and ISG15 promoted the cell stemness of GBM, and increased cell proliferation, sphere formation, migration, invasion, and chemoresistance. Moreover, HERC5 and ISG15 played a synergistic role in promoting the cell stemness of GBM. We also found that HERC5/ISG15 promoted the stability of SERBP1, which also promoted the cell stemness of GBM. The tumor-promoting role of HERC5 and ISG15 was also confirmed in a subcutaneous xenograft tumor model. Collectively, HERC5/ISG15 was found to regulate GBM stemness and tumor progression by mediating SERBP1 protein stability. Our present study suggests a promising therapeutic target for GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaUbiquitinsNeoplastic Stem CellsBrain NeoplasmsCytokinesRNA-Binding ProteinsProtein StabilityMice, NudeCell ProliferationHumansAnimalsMiceCell Line, TumorDisease ProgressionTemozolomideGene Expression Regulation, NeoplasticMaleApoptosisFemaleCell MovementXenograft Model Antitumor AssaysDrug Resistance, NeoplasmUbiquitin-Protein LigasesIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

GlioblastomaISG15ISGylationProgressionStemness

Substanzen

UbiquitinsISG15 protein, humanCytokinesRNA-Binding ProteinsHERC5 protein, humanTemozolomideUbiquitin-Protein LigasesIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Neurosurgery, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, Henan Province, China.
  • Department of Neurosurgery, People's Hospital of Henan University, Zhengzhou, China.
  • Department of Neurosurgery, People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Neurosurgery, Henan Provincial People's Hospital, No. 7 Weiwu Road, Zhengzhou, 450003, Henan Province, China. chxma2016@henu.edu.cn.
  • Department of Neurosurgery, People's Hospital of Henan University, Zhengzhou, China. chxma2016@henu.edu.cn.
  • Department of Neurosurgery, People's Hospital of Zhengzhou University, Zhengzhou, China. chxma2016@henu.edu.cn.

Förderung

  • Natural Science Foundation of Henan Province

Zitieren

APA

Li, Z., Qian, R., Li, M., Li, J., Guo, Y., Zhou, Y., & Ma, C. (2025). HERC5/ISG15 Enhances Glioblastoma Stemness and Tumor Progression by mediating SERBP1protein stability. NeuroMolecular Medicine, 27(1). https://doi.org/10.1007/s12017-024-08826-w

Vancouver

Li Z, Qian R, Li M, Li J, Guo Y, Zhou Y, et al. HERC5/ISG15 Enhances Glioblastoma Stemness and Tumor Progression by mediating SERBP1protein stability. NeuroMolecular Medicine. 2025;27(1). doi:10.1007/s12017-024-08826-w

BibTeX
@article{Li2025,
  author = {Li, Zhixiao and Qian, Rongjun and Li, Mengda and Li, Juntao and Guo, Yongji and Zhou, Yuanhang and Ma, Chunxiao},
  title = {HERC5/ISG15 Enhances Glioblastoma Stemness and Tumor Progression by mediating SERBP1protein stability},
  journal = {NeuroMolecular Medicine},
  year = {2025},
  volume = {27},
  number = {1},
  doi = {10.1007/s12017-024-08826-w}
}
Kostenlos starten →